HDII (Hypertension Diagnostics) Market Cap: $0.00 Mil (As of Jun. 25, 2026)


What is Hypertension Diagnostics Market Cap?

Hypertension Diagnostics HDII -99.00% Market Cap is $0.00 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hypertension Diagnostics's share price for the quarter that ended in Sep. 2019 was $0.014. Hypertension Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2019 was 52.39 Mil. Therefore, Hypertension Diagnostics's market cap for the quarter that ended in Sep. 2019 was $0.73 Mil.

Hypertension Diagnostics's quarterly market cap increased from Mar. 2019 ($0.09 Mil) to Jun. 2019 ($0.49 Mil) and increased from Jun. 2019 ($0.49 Mil) to Sep. 2019 ($0.73 Mil).

Hypertension Diagnostics's annual market cap stayed the same from Dec. 2016 ($0.00 Mil) to Dec. 2017 ($0.00 Mil) but then increased from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.07 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hypertension Diagnostics's Enterprise Value for Today is $0.00 Mil.

Hypertension Diagnostics  (OTCPK:HDII) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Hypertension Diagnostics Market Cap Related Terms

Hypertension Diagnostics Market Cap Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Market Cap Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.33 1.26 0.00 0.00 0.07

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.07 0.09 0.49 0.73

HDII vs ESTRF, OCLN, PTOI: Market Cap Comparison

For the Shell Companies subindustry, Hypertension Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics Market Cap vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's Market Cap falls into.


Hypertension Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hypertension Diagnostics's Market Cap for the fiscal year that ended in Dec. 2018 is calculated as

Market Cap (A: Dec. 2018 )=Share Price (A: Dec. 2018 )*Shares Outstanding (EOP) (A: Dec. 2018 )
=$0.0013*52.389
=$0.07

Hypertension Diagnostics's Market Cap for the quarter that ended in Sep. 2019 is calculated as

Market Cap (Q: Sep. 2019 )=Share Price (Q: Sep. 2019 )*Shares Outstanding (EOP) (Q: Sep. 2019 )
=$0.014*52.389
=$0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
Hypertension Diagnostics (HDII) has a Market Cap of $0.00 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Market Cap too high?
Hypertension Diagnostics' current Market Cap is $0.00 Mil.
How does Hypertension Diagnostics' Market Cap compare to ESTRF and OCLN?
Hypertension Diagnostics' Market Cap of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. The industry median Market Cap is 84.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Diversified Financial Services company?
The median Market Cap among Diversified Financial Services companies is 84.50, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hypertension Diagnostics and its competitors. For the Diversified Financial Services industry, the median Market Cap is 84.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypertension Diagnostics's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Market Cap is $0.00 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.